Is buying £1,000 of Rolls-Royce shares a smart investment?

The shares of Rolls-Royce are a top pick for financial institutions, but are there better opportunities available to investors today?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rolls-Royce (LSE:RR) shares are one of the most popular stocks to own in the UK. In fact, some financial institutions seem to be very fond of it. As much as 30% of the business is held by only 10 of them, mostly involved with pensions. But while the professionals might be obsessed with this engineering giant, is this popularity warranted? And if not, then where should I be looking to invest?

A closer look at Rolls-Royce shares

Investors who bought Rolls-Royce shares a few years ago are likely looking at a red mark in their portfolio. That’s because, over the last five years, this stock has fallen by around 45%. Most of this decline was seen in early 2020 after the pandemic decimated its aerospace revenue stream. But even if I look at share price performance between December 2016 and 2019, it only climbed by a mediocre 4.6%. That doesn’t even beat inflation on an annualised basis. So, what happened?

For a long time, the financial state of this enterprise has been pretty dire. Only one out of the last five years have been profitable, which pushed management to take on considerable debt even before the pandemic reared its ugly head. Needless to say, that’s not the sign of a healthy and thriving business. And with Covid-19 only exacerbating the problem, I’m not surprised to see the stock take such a massive hit.

But recently, the situation has improved. The company is undergoing some fairly massive restructuring to cut costs. And its aerospace division is back on the mend as demand returns for its aircraft maintenance services. Therefore, Rolls-Royce shares may be primed to make a rapid comeback in 2022. And if that were to happen, then an investment as small as £1,000 could prove to be quite lucrative. But is there an even better buying opportunity elsewhere? I think there is.

Fallen from grace but capable of rising again

When investigating Rolls-Royce shares, many investors like to focus on its aerospace division. After all, it’s the group’s primary revenue source. However, it also has sizeable operations within the defence industry. That’s a sector in which Avon Protection (LSE:AVON) has recently fallen from grace as far as the market is concerned.

Avon designs and manufactures personal protective equipment for the armed forces as well as first-responders. And until recently, the stock was thriving, reaching as high as 4,650p in early December 2020. However, looking at the share price today, almost all the gains made in the last five years have been wiped out. There are undoubtedly numerous reasons why shares of Avon Protection have collapsed. However, one leading factor is a failed body armour test for the US Defence Logistics Agency, which significantly impacted growth expectations.

Yet the income from its flagship respirator and ballistic helmet product lines remains uncompromised, with double-digit growth still being delivered. That’s why I believe investors may have overreacted, creating a buying opportunity for my portfolio. And with a much stronger balance sheet than Rolls-Royce, these shares look like a better comeback story, in my opinion. As such, I’m not convinced buying Rolls-Royce would be so smart for me. I’d ignore Rolls-Royce and buy Avon for my portfolio.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Avon Protection. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »